Treatment Clinical Trials for Kaposi Sarcoma

Review the Kaposi sarcoma treatment clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-10 of 10

A Phase 2 Trial of Ixazomib for Kaposi Sarcoma
Status: Active
Location: 15 locations
Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor for the Treatment of Non-rhabdomyosarcoma Soft Tissue Sarcoma
Status: Active
Location: 3 locations
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
Status: Active
Location: 2 locations
Propranolol for the Treatment of Adult Patients with Kaposi Sarcoma
Status: Active
Location: Siteman Cancer Center at Washington University, Saint Louis, Missouri
Abemaciclib for the Treatment of Patients with HIV-Associated and HIV-Negative Kaposi Sarcoma
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
NHS-IL12 Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
A Study of sEphB4-HSA in Kaposi Sarcoma
Status: Active
Location: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas
Pomalidomide and Nivolumab for the Treatment of Virus-Associated Malignancies with or without HIV
Status: Active
Location: National Institutes of Health Clinical Center, Bethesda, Maryland
Paclitaxel or Liposomal Doxorubicin for HIV-positive Persons with Kaposi Sarcoma
Status: Approved
Location: Location information is not yet available.